Elucidating the specific pharmacological mechanism of action (MOA) of naturally transpiring compounds is usually challenging. Although Tarselli et al. (60) designed the main de novo artificial pathway to conolidine and showcased that this naturally transpiring compound efficiently suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic target https://davyk008zci4.slypage.com/profile